The GlaxoSmithKline plc (GSK) Earns “Buy” Rating from Bryan, Garnier & Co

The GlaxoSmithKline plc (GSK) Earns “Buy” Rating from Bryan, Garnier & Co

A number of other equities research analysts have also weighed in on the company. HSBC Holdings plc reaffirmed a buy rating and set a GBX 1,970 ($25.31) target price on shares of GlaxoSmithKline plc in a research report on Wednesday, May 31st. JPMorgan Chase & Co. reaffirmed a neutral rating and set a GBX 1,750 ($22.48) target price on shares of GlaxoSmithKline plc in a research report on Monday, May 29th. Morgan Stanley set a GBX 1,700 ($21.84) target price on GlaxoSmithKline plc and gave the company a neutral rating in a research report on Monday, May 29th. Deutsche Bank AG reaffirmed a hold rating and set a GBX 1,720 ($22.09) target price on shares of GlaxoSmithKline plc in a research report on Monday, May 29th. Finally, Berenberg Bank raised GlaxoSmithKline plc from a hold rating to a buy rating and lifted their target price for the company from GBX 1,850 ($23.76) to GBX 1,885 ($24.21) in a research report on Friday, May 26th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and nine have issued a buy rating to the stock. The stock currently has an average rating of Hold and an average target price of GBX 1,751.77 ($22.50).

Bryan, Garnier & Co restated their buy rating on shares of GlaxoSmithKline plc (LON:GSK) in a report issued on Wednesday. The brokerage currently has a GBX 1,750 ($22.48) price target on the stock.

Shares of GlaxoSmithKline plc (GSK) opened at 1695.0664 on Wednesday. The stock’s market capitalization is GBX 82.82 billion. The company has a 50-day moving average price of GBX 1,620.99 and a 200 day moving average price of GBX 1,592.49. GlaxoSmithKline plc has a 52 week low of GBX 1,363.00 and a 52 week high of GBX 1,745.56. The company also recently declared a dividend, which will be paid on Thursday, July 13th. Shareholders of record on Thursday, May 11th will be given a dividend of GBX 19 ($0.24) per share. The ex-dividend date of this dividend is Thursday, May 11th. This represents a yield of 1.21%.

In other news, insider Moncef Slaoui purchased 56 shares of the stock in a transaction on Tuesday, March 7th. The stock was bought at an average price of GBX 2,072 ($26.62) per share, with a total value of £1,160.32 ($1,490.46). Also, insider Dominic Redfern purchased 230 shares of the stock in a transaction on Thursday, April 13th. The shares were purchased at an average cost of GBX 1,639 ($21.05) per share, with a total value of £3,769.70 ($4,842.26). In the last ninety days, insiders have acquired 718 shares of company stock valued at $1,183,024. GlaxoSmithKline plc Company Profile

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “LSE:GSK”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Related posts

Leave a Comment